302 related articles for article (PubMed ID: 17583833)
1. [Which rate describes the MRSA situation appropriately?].
Gastmeier P; Chaberny IF
Dtsch Med Wochenschr; 2007 Jul; 132(27):1480-2. PubMed ID: 17583833
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit.
Ibelings MM; Bruining HA
Eur J Surg; 1998 Jun; 164(6):411-8. PubMed ID: 9696441
[TBL] [Abstract][Full Text] [Related]
4. [Impact of methicillin resistance in S. aureus].
Talon D
Pathol Biol (Paris); 1999 Oct; 47(8):819-26. PubMed ID: 10573702
[TBL] [Abstract][Full Text] [Related]
5. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
6. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
Gould IM
Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
[TBL] [Abstract][Full Text] [Related]
7. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
Melzer M; Eykyn SJ; Gransden WR; Chinn S
Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
10. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
[TBL] [Abstract][Full Text] [Related]
11. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery.
Mastoraki A; Kriaras I; Douka E; Mastoraki S; Stravopodis G; Geroulanos S
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):452-6. PubMed ID: 18346978
[TBL] [Abstract][Full Text] [Related]
13. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
[TBL] [Abstract][Full Text] [Related]
14. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits.
Reddy SL; Grayson AD; Smith G; Warwick R; Chalmers JA
Eur J Cardiothorac Surg; 2007 Jul; 32(1):113-7. PubMed ID: 17434315
[TBL] [Abstract][Full Text] [Related]
15. [The Dutch MRSA policy should be retained].
Vlaminckx BJ; Troelstra A; van der Bruggen T
Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
[TBL] [Abstract][Full Text] [Related]
16. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
[TBL] [Abstract][Full Text] [Related]
17. The evolution of Staphylococcus aureus.
Deurenberg RH; Stobberingh EE
Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus infections in Australasian neonatal nurseries.
Isaacs D; Fraser S; Hogg G; Li HY
Arch Dis Child Fetal Neonatal Ed; 2004 Jul; 89(4):F331-5. PubMed ID: 15210669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
